Singapore’s KPB Biosciences fails in bid to unfreeze assets in US$830 million Novo Nordisk legal battle
Locally headquartered biotech firm KPB Biosciences has failed to set aside a court order for its assets to be frozen, ...
Locally headquartered biotech firm KPB Biosciences has failed to set aside a court order for its assets to be frozen, ...
In what Science magazine has dubbed “Novo Nordisk’s Canadian Mistake,” Ozempic is soon to come off patent in Canada, opening ...
Published Fri, Jun 13, 2025 · 05:38 PM Novo Nordisk reclaimed its position as Europe’s most valuable public company, overtaking ...
This follows executive orders by President Donald Trump to stop diversity, equity and inclusion initiativesPublished Wed, May 7, 2025 · ...
Novo Nordisk is seeking as much as US$830 million in damages in a Singapore court, saying that it was misled ...
EUROPE’S Stoxx 600 closed slightly higher at the start of a holiday-shortened week, as a spike in Novo Nordisk shares ...
The price for a month’s supply of the starter dose of Wegovy will be 1,400 yuanNovo Nordisk said on Monday ...
Danish pharmaceutical giant Novo Nordisk, maker of the blockbuster diabetes and weight-loss drugs Ozempic and Wegovy, posted on Wednesday (Nov ...
RUSSIA’S oil producers Rosneft and Lukoil will sharply cut oil exports from the Black Sea port of Novorossiisk in July, ...
Danish pharmaceutical giant Novo Nordisk posted bumper profits for 2023 on Wednesday, driven by blockbuster sales of diabetes and obesity ...
The NY Journals pride themselves on assembling a proficient and dedicated team comprising seasoned journalists and editors. This collective commitment drives us to provide our esteemed readership with nothing short of the most comprehensive, accurate, and captivating news coverage available.
Transcending the bounds of New York City to encompass a broader scope, we ensure that our audience remains well-informed and engaged with the latest developments, both locally and beyond.
© 2025 The New York Journals. All Rights Reserved.